
CKBR-12 Parkinson Treatment – A Novel Ibogaine Derivative Medicine CKBR-12 Parkinson Treatment is an emerging ibogaine derivative medicine currently being evaluated for its effectiveness in reducing both motor and[…]

Ibogaine treatment for Parkinson’s disease is an emerging approach being studied for its potential effects on motor and non-motor symptoms of PD. More than 55 million people globally suffer[…]

The Long, Strange Trip of Rick PerryThe former Texas governor and Trump energy secretary has now dedicated his life to promoting the powerful psychedelic ibogaine.Robert DraperBy Robert DraperReporting from[…]

Home / News Release / Senate budget would fund first-in-the-nation study of ibogaine treatment for opioid use disorder A proviso in the Washington Legislature’s supplemental operating budget would direct[…]

Ibogaine Treatment For Various Addictions is an emerging therapeutic approach being explored for its role in addiction recovery and withdrawal management. In today’s post, we will take an in-depth[…]

The Day I Was Lobotomised by a Plant 15 minute read Much has been written in recent times about the benefits of psychedelic/oneiro genic plant medicines in treating addiction[…]

New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.[…]